A bispecific peptide-drug conjugate for tumor macrophages

A peptide-drug conjugate blocks PD‑L1 and LAG‑3 and conditionally releases a TLR7/8 agonist in tumors, aiming to repolarize macrophages and boost T-cell activity with less systemic toxicity.